Lack Of Incentives Threatens AMR Investment
Over A Third Of AMRIA Members Have Said They Could Cut AMR Spending
The AMR Industry Alliance’s 2021 progress report has found that the life sciences industry is helping to shape a positive future outlook in the fight against antimicrobial resistance despite supply-chain disruptions for generics firms, but continued cross-sector collaborations along with policy and regulatory changes toward a more sustainable marketplace are needed.
